Tuesday Oct. 17
1:30–2:15 PM ET

Achieving Equity in Alzheimer's Disease

As Alzheimer’s therapies continue to make great progress, questions remain about how we can ensure equitable access to the right treatments, for the right patients, at the right time. What do we know--and not know--about the etiology of the disease in and the impact of new treatments on minoritized, and especially Black, populations?  Key Question: How do we achieve success with such low rates of racial and ancestral diversity in clinical trials?

Featured Speakers

Stephanie Monroe